H. pylori test and treat in case of unexplained ... containing triple therapy is not recommended as first-line treatment Sequential therapy is discussed as option of choice (days 1–5: PPI ...

In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert ...

This nod came after Dr. Reddy’s laboratories presented the bioequivalence study report before the committee. Esomeprazole is ...

Gender differences can also influence a persons risk of developing stomach cancer An expert explains who is at a greater risk ...

Integrating AI in gastrointestinal endoscopy enhances image analysis, reduces diagnostic variability, and improves patient ...

Discover the role of proton-pump inhibitors (PPIs) in managing gastrointestinal disorders. Get insights into their uses, ...

The Subject Expert Committee (SEC) of the central drug regulatory authority has recommended grant of approval to Dr Reddy's Laboratory for import and market new drug Tegoprazan in the country for use ...

India’s rich culinary heritage, while celebrated globally, may contribute to gastric cancer risk in some cases.

Several factors contribute to the development of stomach cancer, with some being more preventable than others: Helicobacter pylori infection: This bacterium is a leading cause of stomach cancer, ...

and we look forward to bringing these innovative vonoprazan-based treatment options to the millions of H pylori sufferers in the US," she said. Vonoprazan was developed by Takeda's ...

Most of us experience nausea or pressure in the abdominal area from time to time, and if the symptoms persist for a long time ...